Skip to main content
SLDB logo

SLDB · Solid Biosciences Inc. · Debt

Track SLDB — free
$6.25 -0.19 (-2.95%) At close · Nov 20 Q1 2022 earnings call transcript
Market Cap
$697.57M
Shares
111.61M
Volume · Nov 20 1.56M Avg daily vol (3M) 1.29M

Debt Profile

Completed filing coverage through Jun 16, 2021

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-09-30 USD 2,284,000 10-Q filed 2026-11-04
Noncurrent operating lease liabilities 2026-09-30 USD 17,340,000 10-Q filed 2026-11-04
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1707502 CUSIP 83422E204 13F (30d) 160 filings 144 filers Visit website Investor relations